WST West Pharmaceutical Services, Inc.
650
$365.59
$1.07
(0.29%)
| Watchers | 650 |
| 52-Wk Low | $310.42 |
| 52-Wk High | $415.73 |
| Market Cap | $26.71B |
| Volume | 795,476.00 |
| 52-Wk High | $415.73 |
| 52-Wk Low | $310.42 |
West to Participate in Upcoming Investor ConferencePR Newswire • 10 days ago
West to Participate in Upcoming Investor Conference West to Participate in Upcoming Investor Conference PR Newswire EXTON, Pa., April 30, 2024 EXTON, Pa., April 30, 2024 /PRNewswire/ -- West...
Share to Feed
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend PR Newswire EXTON, Pa., April 25...
West to Host First-Quarter 2024 Conference Call West to Host First-Quarter 2024 Conference Call PR Newswire EXTON, Pa., April 11, 2024 EXTON, Pa., April 11, 2024 /PRNewswire/ --West Pharmaceutical...
Park Place Capital Corp decreased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 32.7% during the fourth quarter, according to the company in its most recent...
State of Michigan Retirement System lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 0.5% during the fourth quarter, according to the company in its...
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Mettler-Toledo International, Inc. (MTD) has taken over the #284 spot from West Pharmaceutical...
Venturi Wealth Management LLC cut its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 6.8% during the fourth quarter, Holdings Channel reports. The institutional...
Caprock Group LLC reduced its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent Form 13F filing with...
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 Mid Cap Growth Strategy investor letter, a copy of which can be downloaded here. The strategy outperformed...
Raymond James Associates increased its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 8.6% in the 4th quarter, according to its most recent 13F filing with the...